OR WAIT null SECS
Rita Peters is editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.
Peer-reviewed papers and technical articles can help advance bio/pharmaceutical development.
FDA’s Center for Drug Evaluation and Research (CDER) has been encouraging industry to invest in quality drug production methods and improve processes, facilities, and equipment. Such advances in processing are built on an exchange of scientific and technical information.
Players in bio/pharmaceutical development and manufacturing-from bio/pharma companies and industry suppliers-have a wealth of scientific and technical expertise about biopharmaceutical formulation, development, and manufacturing. Sharing this knowledge-in an objective format-is vital to the growth and improvement of the bio/pharma industry.
For nearly 40 years, Pharmaceutical Technology magazine has taken a leadership role in sharing information about bio/pharmaceutical formulation, development, and processing methods, technologies, and practices. With a dedication to providing objective, informed content, the magazine and www.PharmTech.com are excellent media channels for this information exchange.
Article formats vary from peer-reviewed papers, non peer-reviewed technical papers, and business-focused articles. The editors welcome contributions from experts in the bio/pharmaceutical development community. All contributions, both peer-review submissions and technical articles, should be written with the following four guidelines in mind.
Articles and papers must be based on technical and scientific fact, supported by references to published literature or data. Marketing-based language, unsupported claims, or promotional language are not acceptable in editorial features.
Manuscripts are reviewed with the understanding that the content has not been published previously in any format, including print or electronic publications, conference proceedings, whitepapers, application notes, posters, or company-created marketing or sales literature. The article submission should not be ghostwritten. In addition, it should not be under consideration for publication with any other print or digital publication, in any language.
The author must own the rights to the submitted content, including all images, tables, and figures. Graphics from other sources or third-party sources will not be accepted for publication. Before a manuscript is accepted for publication, all authors must sign a license agreement to provide Pharmaceutical Technology permission to publish the original article and its associated figures/tables in print and online. Authors retain the copyright to the article, as it was originally submitted.
The editors seek objective articles on technical and regulatory subjects including process development, manufacturing, formulation, drug delivery, API synthesis, analytical technology and testing, primary packaging, IT, outsourcing, supply chain, serialization, and regulatory compliance. Consult the editorial calendar for a list of current topics. Upcoming topics include taste masking, drug reformualtion, combination products, parenteral manufacturing and process controls.
If you have an important technical, regulatory, or process improvement topic to share with peers in the industry, I encourage you to share it through Pharmaceutical Technology. Please visit www.PharmTech.com/Contribute and review the author’s guidelines and editorial calendar. Then, send me a message or give me a call. I would be happy to discuss your ideas for objective editorial contributions.
Article DetailsPharmaceutical Technology
Vol. 39, No. 6
Citation: When referring to this article, please cite it as R. Peters, " Help Build Better Bio/Pharma Processes," Pharmaceutical Technology39 (6) 2015.